5 followers
Kymera is a clinical stage biopharmaceutical company focused on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body’s own natural protein degradation system.
Nello Mainolfi
Kura Oncology
20 followers
Summit Therapeutics
5 followers
Arbutus Biopharma
2 followers
Fortis Life Sciences
1 follower
Click Therapeutics
1 follower
Humacyte
1 follower
Fractyl
1 follower
BillionToOne
1 follower
Immunai
2 followers
Fulcrum Therapeutics
2 followers
Thermo Fisher Scientific
184 followers
Explore companies